Fund Holdings — Ikarian Capital, LLC

Total Portfolio Value:
$504.12M
Total Bought:
$112.98M
Total Sold:
$224.24M
Net Transaction:
-$111.26M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kodiak Sciences Inc.(KOD)1,059,730533,113-526,617$41.29M$50.54M10.03%+$9.25M
ABIVAX Société AnonymeADS(ABVX)328,635285,909-42,726$43.35M$28.44M5.64%-$14.91M
Vaxcyte, Inc.(PCVX)388,682400,465+11,783$22.59M$22.79M4.52%+$192.4K
Arcus Biosciences, Inc.(RCUS)504,559734,559+230,000$15.56M$18.97M3.76%+$3.42M
Celldex Therapeutics, Inc.(CLDX)478,500518,500+40,000$17.80M$16.80M3.33%-$1.00M
Amylyx Pharmaceuticals, Inc.(AMLX)117,500561,459+443,959$2.11M$16.34M3.24%+$14.23M
Pharvaris N V
COM
308,856502,372+193,516$10.68M$15.94M3.16%+$5.25M
Vera Therapeutics, Inc.CL A(VERA)310,000400,000+90,000$13.30M$12.92M2.56%-$386.1K
Alto Neuroscience, Inc.(ANRO)407,338482,338+75,000$10.75M$12.31M2.44%+$1.56M
Cogent Biosciences, Inc.(COGT)370,084370,0840$14.32M$11.85M2.35%-$2.47M
ANI Pharmaceuticals, Inc.(ANIP)272,085149,065-123,020$22.52M$10.83M2.15%-$11.69M
Enliven Therapeutics Inc126,541232,055+105,514$6.42M$10.64M2.11%+$4.22M
Maze Therapeutics, Inc.(MAZE)378,999301,402-77,597$11.31M$8.19M1.63%-$3.12M
Contineum Therapeutics, Inc.CL A(CTNM)807,874594,666-213,208$13.24M$7.98M1.58%-$5.26M
Cue Biopharma, Inc.(CUE)104,364290,633+186,269$3.29M$7.52M1.49%+$4.22M
Eupraxia Pharmaceuticals Inc.(EPRX)809,741809,7410$5.35M$7.37M1.46%+$2.02M
Tectonic Therapeutic, Inc.(TECX)205,837306,338+100,501$7.08M$7.13M1.42%+$59.0K
ORIC Pharmaceuticals, Inc.(ORIC)0522,765+522,765$0$7.04M1.40%+$7.04M
Monopar Therapeutics Inc.(MNPR)47,86186,761+38,900$4.43M$6.91M1.37%+$2.48M
C4 Therapeutics, Inc.(CCCC)2,433,0001,933,000-500,000$11.36M$6.44M1.28%-$4.93M
Alpha Cognition Inc. Common Stock(ACOG)836,259701,259-135,000$6.04M$6.31M1.25%+$273.5K
Immunome, Inc.(IMNM)60,000285,000+225,000$1.27M$6.13M1.22%+$4.86M
Jade Biosciences Inc427,349427,3490$9.50M$6.00M1.19%-$3.49M
Helus Pharma Inc(HELP)132,153487,575+355,422$873.5K$5.99M1.19%+$5.12M
Faeth Therapeutics, Inc.(FTH)35,386199,694+164,308$884.6K$5.94M1.18%+$5.05M
Damora Therapeutics Inc0275,710+275,710$0$5.87M1.16%+$5.87M
Freenome Inc0362,626+362,626$0$5.71M1.13%+$5.71M
Proqr Thrapeutics N VSHS EURO
SHS EURO
3,425,9303,425,9300$6.37M$5.69M1.13%-$685.2K
Cardiol Therapeutics Inc.CL A(CRDL)3,325,0003,325,0000$3.52M$5.52M1.09%+$2.00M
Relmada Therapeutics, Inc.(RLMD)2,148,3591,448,359-700,000$14.87M$5.46M1.08%-$9.41M
Pelthos Therapeutics Inc.(PTHS)256,598256,5980$7.25M$5.39M1.07%-$1.86M
Ovid Therapeutics Inc.(OVID)2,269,7042,119,704-150,000$6.11M$5.28M1.05%-$827.4K
Spruce Biosciences Inc121,356101,356-20,000$6.55M$4.92M0.98%-$1.63M
Vor Biopharma Inc.(VOR)0250,000+250,000$0$4.77M0.95%+$4.77M
Vogenx Inc0208,836+208,836$0$4.76M0.94%+$4.76M
Viridian Therapeutics, Inc.(VRDN)425,000225,000-200,000$7.81M$4.63M0.92%-$3.17M
Bright Minds Biosciences Inc.(DRUG)88,95188,9510$6.24M$4.43M0.88%-$1.81M
Zura Bio LimitedCL A(ZURA)1,218,4921,018,492-200,000$7.19M$4.24M0.84%-$2.95M
Inventiva S.A.ADS(IVA)1,129,1011,129,1010$4.15M$4.22M0.84%+$62.7K
Cumberland Pharmaceuticals Inc.(CPIX)503,153503,1530$3.26M$3.94M0.78%+$679.3K
Septerna, Inc.(SEPN)0100,047+100,047$0$3.91M0.78%+$3.91M
Rezolute, Inc.(RZLT)935,012935,0120$4.86M$3.87M0.77%-$991.1K
Amanat Acquisition CorpCL A150,000349,836+199,836$1.52M$3.73M0.74%+$2.20M
CAMP4 THERAPEUTICS CORPORATION(CAMP)0912,906+912,906$0$3.69M0.73%+$3.69M
Ocugen, Inc.(OCGN)3,962,9723,562,972-400,000$6.06M$3.67M0.73%-$2.39M
Alector Inc1,982,6061,982,6060$3.99M$3.67M0.73%-$317.2K
Olema Oncology, Inc.(OLMA)383,281383,2810$4.79M$3.31M0.66%-$1.48M
Silence Therapeutics plcADS(SLN)830,784821,790-8,994$1.83M$3.29M0.65%+$1.46M
Ginkgo Bioworks Holdings, Inc.CL A(DNA)0250,000+250,000$0$3.21M0.64%+$3.21M
Quince Therapeutics Inc72,25195,652+23,401$1.31M$2.97M0.59%+$1.65M
Q32 Bio Inc.(QTTB)430,000345,000-85,000$5.48M$2.85M0.57%-$2.63M
Arvinas, Inc.(ARVN)358,257358,2570$2.98M$2.77M0.55%-$206.0K
Connect Biopharma Holdings LimitedSHS(CNTB)4,538,5342,235,534-2,303,000$10.80M$2.46M0.49%-$8.34M
Rein Therapeutics Inc.(RNTX)2,950,0002,950,0000$3.07M$2.37M0.47%-$696.2K
Kazia Therapeutics LimitedADS(KZIA)396,201246,201-150,000$5.58M$2.36M0.47%-$3.22M
Acumen Pharmaceuticals, Inc.(ABOS)1,053,7971,053,7970$2.81M$2.34M0.46%-$474.2K
Invivyd, Inc.(IVVD)2,656,5702,656,5700$2.32M$2.31M0.46%-$6.1K
Acadia Pharmaceuticals Inc28,099112,000+83,901$710.9K$2.26M0.45%+$1.55M
ProMIS Neurosciences, Inc.(PMN)205,000205,0000$2.70M$2.22M0.44%-$473.6K
Crescent Biopharma, Inc.(CBIO)0150,061+150,061$0$2.19M0.43%+$2.19M
Obsidian Therapeutics Inc0158,942+158,942$0$2.18M0.43%+$2.18M
Capricor Therapeutics, Inc.(CAPR)604,215229,215-375,000$14.55M$2.17M0.43%-$12.38M
Delcath Systems, Inc.(DCTH)185,667135,667-50,000$2.34M$2.17M0.43%-$170.9K
4d Molecular Therapeutics In0150,037+150,037$0$2.15M0.43%+$2.15M
Praxis Precision Medicines, Inc.(PRAX)72,8426,942-65,900$24.39M$2.02M0.40%-$22.37M
Neuronetics, Inc.(STIM)701,182810,182+109,000$911.5K$1.90M0.38%+$984.3K
Biohaven Ltd.(BHVN)748,181133,181-615,000$11.13M$1.78M0.35%-$9.35M
Lexeo Therapeutics, Inc.(LXEO)513,011513,0110$2.39M$1.73M0.34%-$654.1K
Verastem, Inc.(VSTM)213,865213,8650$817.0K$1.72M0.34%+$904.6K
Journey Medical Corporation(DERM)251,436251,4360$1.78M$1.72M0.34%-$60.3K
Immunic, Inc.(IMUX)67,464182,464+115,000$1.04M$1.70M0.34%+$660.0K
PepGen Inc.(PEPG)447,165693,539+246,374$804.9K$1.68M0.33%+$873.5K
Fulcrum Therapeutics, Inc.(FULC)1,049,161449,161-600,000$3.84M$1.66M0.33%-$2.18M
Tyra Biosciences, Inc.(TYRA)065,000+65,000$0$1.42M0.28%+$1.42M
Avalo Therapeutics, Inc.(AVTX)90,18390,1830$1.67M$1.38M0.27%-$284.1K
Cabaletta Bio, Inc.(CABA)700,000700,0000$2.18M$1.34M0.27%-$833.0K
Tarsus Pharmaceuticals, Inc.(TARS)31,16616,858-14,308$1.96M$1.33M0.26%-$636.4K
uniQure N.V.SHS(QURE)049,800+49,800$0$1.20M0.24%+$1.20M
Palatin Technologies, Inc.(PTN)0130,000+130,000$0$1.15M0.23%+$1.15M
iBio, Inc.(IBIO)957,062957,0620$1.67M$1.13M0.22%-$545.5K
Lipocine Inc.(LPCN)508,556508,5560$1.30M$1.12M0.22%-$183.1K
Pliant Therapeutics, Inc.(PLRX)1,000,0001,000,0000$1.14M$1.08M0.21%-$60.0K
DBV Technologies S.A.ADS(DBVT)525,000453,374-71,626$1.69M$1.07M0.21%-$625.6K
Harrow, Inc.(HROW)135,77533,275-102,500$5.77M$1.02M0.20%-$4.74M
Quoin Pharmaceuticals, Ltd.ADS(QNRX)211,538211,5380$1.02M$964.6K0.19%-$59.2K
Jasper Therapeutics, Inc.(JSPR)24,0931,342,626+1,318,533$10.1K$778.7K0.15%+$768.6K
Neumora Therapeutics, Inc.(NMRA)1,278,4081,278,4080$2.17M$762.2K0.15%-$1.41M
CNS Pharmaceuticals, Inc.(CNSP)135,830135,8300$649.3K$719.9K0.14%+$70.6K
Kalaris Therapeutics, Inc.(KLRS)360,000248,257-111,743$1.47M$717.5K0.14%-$747.7K
EyePoint, Inc.(EYPT)0205,056+205,056$0$670.5K0.13%+$670.5K
AEON Biopharma, Inc.CL A(AEON)02,203,406+2,203,406$0$661.0K0.13%+$661.0K
Tcgx Acquisition CorpCL A050,000+50,000$0$625.5K0.12%+$625.5K
Fractyl Health, Inc.(GUTS)1,100,0001,100,0000$873.8K$598.8K0.12%-$275.0K
Foghorn Therapeutics Inc.(FHTX)0160,000+160,000$0$571.2K0.11%+$571.2K
Adlai Nortye Group Ltd.ADS(ANL)33,89933,8990$389.8K$542.4K0.11%+$152.5K
Palisade Bio, Inc.(PALI)750,000400,000-350,000$1.57M$540.0K0.11%-$1.03M
Equillium, Inc.(EQ)303,555303,5550$971.4K$493.3K0.10%-$478.1K
Sionna Therapeutics, Inc.(SION)085,300+85,300$0$448.7K0.09%+$448.7K
Immatics N.V.SHS(IMTX)48,56948,5690$492.0K$426.4K0.08%-$65.6K
Lyell Immunopharma, Inc.(LYEL)41,08141,0810$577.2K$402.2K0.08%-$175.0K
Page 1 of 2
Ikarian Capital, LLC — 13F Holdings — Q3 2026 | TickerTrail